Guardant Health price target raised to $50 from $34 at Piper Sandler
Piper Sandler analyst David Westenberg raised the firm’s price target on Guardant Health (GH) to $50 from $34 following quarterly results. The ...
Piper Sandler Keeps Their Buy Rating on Guardant Health (GH)
In a report released today, David Westenberg from Piper Sandler maintained a Buy rating on Guardant Health (GH – Research Report), with a price ...
Guardant Health (GH): Among the Best Performing Mid Cap Stocks to Buy According to Analysts
We recently published a list of 10 Best Performing Mid Cap Stocks to Buy According to Analysts. In this article, we are going ...